期刊文献+

脂质体修饰p42丝裂原活化蛋白激酶反义寡核苷酸对心肌肥厚大鼠p42丝裂原活化蛋白激酶表达的影响

Effects of antisense p42-MAPK oligodeoxynucleotide with Liposomes modified on p42-MAPK cardiac hypertrophy of rats
下载PDF
导出
摘要 目的观察p42丝裂原活化蛋白激酶(p42-MAPK)反义寡核苷酸对肾性高血压导致心肌肥厚大鼠p42-MAPK表达的影响。方法纳入健康清洁级SD大鼠30只,建立肾性高血压大鼠模型,分为假手术组、模型组、反义链组、错义链组及脂质体对照组。用脂质体将p42-MAPK反义寡核苷酸转染入相应组别大鼠,测定收缩压、左心室质量指数、心肌细胞直径和面积。免疫印迹法测定p42-MAPK表达。免疫沉淀法测定p42-MAPK活性。结果p42-MAPK反义寡核苷酸能显著降低模型组p42-MAPK表达及活性,下调肥厚重塑相关指标。结论p42-MAPK反义寡核苷酸可能是基因治疗心肌肥厚重塑的新靶点。 Objective To observe effects of p42-MAPK anti-ODN on renovascular hypertension-induced cardiomyocyte hypertrophy. Methods Into the health of clean grade SD rats were 30.Establish the model of renovascular hypertension. Animals were divided into sham-operation group, model group, anti-ODN group, mis-ODN group and lipofectamine group.With the liposome p42-MAPK antisense oligonucleotide was transfected into the appropriate group rats. As indexes of cardiac hypertrophy, SBP, left ventricular mass index, transdiameter of cardiomyocyte and cardiomyocyte area were measured. The expressions of p42-MAPK was assessed using Western blot; the activity of p42-MAPK was assessed by immuno-precipitation. Resulta Anti-ODN ofp42-MAPK decreased the indexes of cardiac hypertrophy, inhibited the expression and activity of p42-MAPK. Conlusion p42-MAPK anti-ODN could be a new target of gene therapy.
作者 刘军委
出处 《湖南中医药大学学报》 CAS 2009年第9期12-14,20,共4页 Journal of Hunan University of Chinese Medicine
关键词 心肌肥厚 丝裂原活化蛋白激酶 反义寡核苷酸 Cardiac hypertrophy Mitogen-activated protein kinase Antisense oligodeoxynucleotide
  • 相关文献

参考文献13

  • 1Liu JC, Cheng TH, Lee HM, et al. Inhibitory effect of trilinolein on angiotensin II-induced cardiomyocyte hypertrophy[J]. Eur J Pharmacol, 2004,484(28): 1-8.
  • 2Sugden PH. Signaling pathways in cardiac myocyte hypertrophy[J]. Ann Med. 2001 ;33:611-622.
  • 3Huang SL,Ding B, Li J, et al.Target selectivity of MAPK phosphorothioate antisense ODN on p42/p44, p38 MAPK, and JNK protein expression and its inhibitory effect on VSMC DNA synthesisp[J]. Acta Pharrnacologica Sinica, 1999,20(7):39-43.
  • 4Glennon PE,Kaddottra S,Sale EM,et al. Depletion ofmitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myoeytes .Circ Res,1996,78:954-961.
  • 5Kennedy RA, Kemp TJ, Sugden PH, Clerk A. Using U0126 to dissect the role of the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade in the regulation of gene expression by endothelin-1 in cardiac myocytes. J Mol Cell Cardiol,2006,41:236-247.
  • 6Frias MA, Rebsamen MC, Gerber-Wicht C, Lang U. Prostaglandin E2 activates Star3 in neonatal rat ventricular caxdiomyocytes: A role in cardiac hypertrophy. Cardiovasc Res,2007,73:57-65.
  • 7Pinzar E, Wang T, Garrido MR, et al. Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells. FEBS Letters 2005,579:5 100-5 104.
  • 8Ptashne M, Gann A. Signal transduction: imposing specificity on kinases. Science,2006,299:1 025-1 027.
  • 9Frey N, Katus HA, Olson EN, et al. Hypertrophy of the heart: a new therapeutic target?[J]. Circulation. 2004,109(13): 1 580-1 589.
  • 10Solit DB, Garraway LA, Pratilas CA, BRAF mutation predicts sensitivity to MEK inhibition. Nature 2005,439:358-362.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部